Lymphedema Completed Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Lymohedema / Lymphoedema / Lymphoedemas / Lymphoedema NOS

IndicationStatusPhase
DBCOND0029071 (Lymphedema)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00393497A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer TreatmentTreatment